
Nucleus Q1 PAT falls 32% YoY to ₹23.9 Cr — far worse ex a ₹9.8 Cr one-off; margins squeezed
Nucleus Software's Q1 FY27 (consolidated) was a weak print across every operating line. Revenue from operations of ₹210.4 Cr fell 3.3% YoY and 6.4% sequentially, and net profit of ₹23.9 Cr dropped 32% YoY — yet even that flatters the quarter, because it carries a ₹9.8 Cr exceptional GAIN (a gratuity and compensated-absences provision write-back) that the year-ago quarter did not have. Strip it out and underlying PAT is only ~₹16 Cr, roughly 54% below last year's ₹35.2 Cr. Profit before exceptional items and tax collapsed 58% YoY to ₹20.3 Cr — that, not the reported number, is the real read on the quarter. The compression sits squarely on costs against a shrinking top line. Employee benefit expense rose 8% YoY to ₹157.2 Cr and operating/other expenses climbed 19% to ₹45.3 Cr while revenue actually fell, dragging net margin to ~11.4% from ~16.2% a year ago. Management had itself warned on the prior call that employee costs would stay elevated (team investments plus the new labour codes), and this quarter confirms that — but revenue did not grow to absorb it. The one-off gain is the mirror image of the ₹22 Cr labour-code provision Nucleus booked in FY26; a remuneration-structure change let it release part of that provision this quarter. The company gives no formal revenue guidance, and the ₹1,044 Cr order book management pointed to last quarter as a forward lever has not yet reached the P&L — India revenue slipped to ₹118.1 Cr and only the Middle East and Far East geographies grew, while South East Asia stayed loss-making at −₹6.6 Cr segment PBT. There is no published sell-side consensus for this smallcap, so there is no street bar to grade against. Alongside the result, the board's ₹12.50/share FY26 final dividend was paid on 28 July, and the company disclosed a ₹47 lakh GST demand it intends to appeal. The standalone numbers tell the same story (PAT ₹22.95 Cr, EPS ₹8.72), with the standalone-vs-consolidated divergence small enough not to change the conclusion.
Key Highlights
- Consolidated PAT ₹23.9 Cr, −32% YoY and −31% QoQ; adjusted for the ₹9.8 Cr exceptional gain, underlying PAT is ~₹16 Cr, ~−54% YoY
- PBT before exceptional items ₹20.3 Cr, −58% YoY — the core operating decline the headline masks
- Revenue from operations ₹210.4 Cr, −3.3% YoY and −6.4% QoQ; net margin ~11.4% vs ~16.2% a year ago
- Employee cost rose 8% YoY to ₹157.2 Cr and other opex +19% to ₹45.3 Cr on a falling top line — the margin squeeze
- Exceptional gain of ₹9.8 Cr = write-back of gratuity (₹6.99 Cr) + compensated-absences (₹2.83 Cr) provisions after a pay-structure revision, reversing part of FY26's ₹22 Cr labour-code charge
- EPS ₹9.07 vs ₹13.37 YoY; standalone PAT ₹22.95 Cr, EPS ₹8.72
- India segment PBT ₹46.7 Cr; South East Asia remained in loss at −₹6.6 Cr PBT; FY26 final dividend ₹12.50/share paid 28 Jul; ₹47 lakh GST demand to be appealed
Price Impact
More from NUCLEUS